KR101051519B1 - Method for manufacturing ginseng-berry extract - Google Patents
Method for manufacturing ginseng-berry extract Download PDFInfo
- Publication number
- KR101051519B1 KR101051519B1 KR1020100131333A KR20100131333A KR101051519B1 KR 101051519 B1 KR101051519 B1 KR 101051519B1 KR 1020100131333 A KR1020100131333 A KR 1020100131333A KR 20100131333 A KR20100131333 A KR 20100131333A KR 101051519 B1 KR101051519 B1 KR 101051519B1
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng fruit
- ginseng
- enzyme
- extract
- weight
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 80
- 241000208340 Araliaceae Species 0.000 claims abstract description 79
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 79
- 235000008434 ginseng Nutrition 0.000 claims abstract description 79
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 74
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 14
- 230000004151 fermentation Effects 0.000 claims abstract description 14
- 238000010025 steaming Methods 0.000 claims abstract description 13
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 8
- 102100026189 Beta-galactosidase Human genes 0.000 claims abstract description 7
- 108010059881 Lactase Proteins 0.000 claims abstract description 7
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 7
- 229940116108 lactase Drugs 0.000 claims abstract description 7
- 239000003021 water soluble solvent Substances 0.000 claims abstract description 7
- 108010059892 Cellulase Proteins 0.000 claims abstract description 6
- 108010030291 alpha-Galactosidase Proteins 0.000 claims abstract description 6
- 102000005840 alpha-Galactosidase Human genes 0.000 claims abstract description 6
- 229940106157 cellulase Drugs 0.000 claims abstract description 6
- 108010059820 Polygalacturonase Proteins 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 229940088598 enzyme Drugs 0.000 claims description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 238000006911 enzymatic reaction Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 244000005700 microbiome Species 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 239000008055 phosphate buffer solution Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 235000021028 berry Nutrition 0.000 claims description 2
- 229940068517 fruit extracts Drugs 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- 241000047339 Salicornia brachystachya Species 0.000 abstract description 3
- 239000012046 mixed solvent Substances 0.000 abstract 1
- 229930182494 ginsenoside Natural products 0.000 description 29
- 229940089161 ginsenoside Drugs 0.000 description 10
- 235000013325 dietary fiber Nutrition 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 4
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 4
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 4
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 4
- 108010030923 hesperidinase Proteins 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 239000008380 degradant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 약용 식물의 열매 추출물의 제조 방법에 관한 것으로, 보다 상세하게는 음용시 장내에서 진세노사이드(ginsenoside) 성분을 보다 효율적으로 흡수할 수 있도록 효소반응 처리되고 미네랄과 식이섬유가 풍부한 인삼 열매 추출물의 제조방법에 관한 것이다.
The present invention relates to a method for producing a fruit extract of a medicinal plant, and more particularly, ginseng fruit is enzymatically treated and rich in minerals and dietary fiber so as to absorb the ginsenoside components more efficiently in the gut when drinking. It relates to a method for preparing an extract.
인삼 열매는 예로부터 상처 치유 및 소갈병 등에 사용되어 왔으며, 항염 및 항산화 기능을 갖는 것으로 알려져 있다. 그러나 인삼 열매는 4년생 이상의 인삼에서만 열리는 데다, 일단 따면 일주일 안에 시들어버리는 까다로운 특성 때문에 과거에는 식용이나 약재로 주목 받지 못했다. 게다가, 인삼 재배농가는 인삼뿌리에 집중돼야 할 사포닌 성분이 열매로 가는 것을 막기 위해 미리 줄기를 일일이 따서 열매가 열리는 것을 원천 봉쇄해 왔다. Ginseng fruit has been used since ancient times for wound healing and small scab, and is known to have anti-inflammatory and antioxidant functions. Ginseng fruit, however, is only open to ginsengs over 4 years old, and once picked up, it has not been noticed in the past as an edible or medicinal herb because of its tricky nature. In addition, ginseng farmers have blocked the opening of the fruit by picking the stems in advance to prevent the saponin, which should be concentrated in the ginseng root, from going to the fruit.
2000년대 들어 심혈관질환 개선과 당뇨병 등에 관련된 연구 등이 진행되어 관심이 고조되고 있다. 인삼열매는 인삼 뿌리에 비해 사포닌함량이 2배 이상 많고 특히 약리작용이 우수한 성분인 진세노사이드 Re는 뿌리보다 30배 이상 많아 여성 호르몬 기능을 보강할 수 있어 젊음의 묘약으로도 불린다고 "Wang, C.Z., Wu, J.A., McEntee, E., Yuan, C. S. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J. Agric. Food Chem. 54(6) : 2261-2266, 2006."에 기재되어 있다. In the 2000s, research on cardiovascular disease improvement and diabetes has been progressing, and interest is increasing. Ginseng fruit contains more than 2 times more saponin than ginseng roots, and especially ginsenoside Re, which is an ingredient with excellent pharmacological action, is more than 30 times higher than roots and can enhance female hormonal function. CZ, Wu, JA, McEntee, E., Yuan, CS Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J. Agric. Food Chem. 54 (6): 2261-2266, 2006. " It is described.
위와 같은 우수한 생리작용 때문에 인삼 열매를 추출하는 다양한 방법이 개발되고 있다. 인삼 열매를 추출하는 선행기술문헌으로서는 특허 제0852138호 "인삼열매와 인삼화병 추출물의 제조방법"을 들 수 있다. Due to the excellent physiological action as described above, various methods of extracting ginseng fruit have been developed. As a prior art document for extracting ginseng fruit, Patent No. 0852138 "The manufacturing method of ginseng fruit and ginseng vase extract" is mentioned.
따라서 본 발명의 목적은 위와 같은 문제점을 해결하기 위하여 안출한 것으로, 섭취 시 체내 대사 효율이 우수한 인삼 열매 추출물의 제조방법을 제공함에 있다. Therefore, an object of the present invention is to devise to solve the above problems, to provide a method for producing a ginseng fruit extract excellent in in vivo metabolic efficiency.
본 발명의 다른 목적은 다량의 미네랄 및 식이섬유를 함유하고 있는 퉁퉁마디(Salicornia herbacea L.)를 EM(Effective Micro-organisms) 활성액으로 발효시킨 EM 발효 함초 추출물을 이용하여 항산화 효율이 우수한 인삼 열매 추출물의 제조방법을 제공함에 있다. Another object of the present invention is to extract the ginseng fruit extract with excellent antioxidant efficiency using EM fermented seaweed extract fermented Salicornia herbacea L. containing a large amount of minerals and dietary fiber with an active micro-organisms (EM) To provide a method of manufacturing.
상기한 목적을 달성하기 위한 본 발명의 인삼열매 추출물은 인삼열매를 열수로 증숙한 후 인삼열매의 수분함량이 12±3%가 되도록 건조하여 분쇄하는 단계와; 상기 분쇄된 인삼열매 분말을 수용성 용매 또는 수용성 용매와 유기 용매가 혼합된 용매에 용해시켜 알파-갈락토시다제(α-galactosidase), 펙티나제(pectinase), 셀룰라제(cellulase), 락타제(lactase) 또는 헤스퍼리디나제(hesperidinase) 중 선택된 1종 또는 2종 이상과 효소 반응시키는 단계와; 상기 효소반응된 조성물에 EM(Effective Micro-organisms) 발효함초액을 혼합하여 추출하는 단계를 포함함을 특징으로 한다. Ginseng fruit extract of the present invention for achieving the above object is the step of drying and grinding the water content of ginseng fruit to 12 ± 3% after steaming ginseng fruit with hot water; The pulverized ginseng fruit powder is dissolved in a water-soluble solvent or a solvent mixed with an aqueous solvent and an organic solvent, and thus alpha-galactosidase, pectinase, cellulase, and lactase ( enzymatically reacting one or two or more selected from lactase) or hesperidinase; It characterized in that it comprises the step of mixing by mixing the enzyme (Effective Micro-organisms) fermentation supernatant to the enzyme-reacted composition.
상기 효소반응조건은 반응온도 10~80℃, pH 2.0~8.0, 기질농도 0.001~10중량%, 효소농도 0.0001~10중량%, 반응시간 5~48시간인 것을 특징으로 한다. The enzyme reaction conditions are characterized in that the reaction temperature 10 ~ 80 ℃, pH 2.0 ~ 8.0, substrate concentration 0.001 ~ 10% by weight, enzyme concentration 0.0001 ~ 10% by weight, reaction time 5 ~ 48 hours.
상기 수용성 용매로는 물, 초산, 인산, 시트레이트 또는 시트레이트-인산완충용액을 사용하고 pH는 2~8 범위로 조절하며, 유기용매로는 에탄올과 같은 알콜용매, 아세토니트릴, 디옥산 또는 디메틸설폭사이드 등을 사용할 수 있다. As the water-soluble solvent, water, acetic acid, phosphoric acid, citrate or citrate-phosphate buffer solution is used and the pH is adjusted in the range of 2 to 8, and as an organic solvent, an alcohol solvent such as ethanol, acetonitrile, dioxane or dimethyl Sulfoxide and the like can be used.
상기 인삼열매의 추출은 효소 반응된 조성물의 중량대비 3~10배량의 정제수에 첨가한 후 최초 정제수의 부피대비 EM발효함초액을 10중량%를 첨가하여 최초 정제수의 부피대비 10~50%가 될 때까지 추출하는 것이 바람직하다. Extraction of the ginseng fruit is added to the purified water of 3 to 10 times the weight of the enzyme-reacted composition and then added 10% by weight of the EM fermentation herb solution to the volume of the first purified water to be 10 to 50% by volume of the first purified water It is preferable to extract until.
상기 인삼열매의 추출은 효소 반응된 조성물의 중량대비 3~10배량의 정제수에 첨가한 후 최초 정제수의 부피대비 EM발효함초액을 10중량%를 첨가하여 60℃~100℃에서 4~48 시간동안 추출하여 것이 바람직하다.
Extraction of the ginseng fruit was added to purified water of 3 to 10 times the weight of the enzyme-reacted composition, and then added 10% by weight of the EM fermented herb solution to the volume of the first purified water for 4 to 48 hours at 60 ℃ ~ 100 ℃ It is preferable to extract.
본 발명의 방법에 의하여 제조된 인삼열매 추출물은 진세노사이드의 체내대사의 효율이 극대화되도록 인삼열매를 열수로 증숙 후 건조, 분쇄한 인삼열매의 분말을 용매에 용해시켜 효소와 효소반응시킴으로써 진세노사이드 성분의 체내대사를 극대화할 수 있고, 미네랄과 식이섬유가 풍부한 EM발효함초액과 혼합하여 추출함으로써 장내에서 진세노사이즈의 흡수를 효과적으로 할 수 있어 진세노사이드의 약리작용을 극대할 수 있다.
The ginseng fruit extract prepared by the method of the present invention is obtained by steaming the ginseng fruit with hot water, maximizing the efficiency of the metabolism of ginsenosides, and then drying and grinding the powder of the ginseng fruit dissolved in a solvent to enzymatic reaction with enzymes. It can maximize the metabolism of the side components and extract the mixture with the fermentation of EM rich fermentation solution rich in minerals and dietary fiber can effectively absorb the ginsenosize in the intestine can maximize the pharmacological action of ginsenosides.
이하 본 발명의 바람직한 실시를 보다 상세하게 설명한다. 그러나 본 발명은 다수의 상이한 형태로 구현될 수 있고, 기술된 실시 예에 제한되지 않음을 이해하여야 한다. 하기에 설명되는 본 발명의 실시 예는 당업자에게 본 발명의 사상을 충분하게 전달하기 위한 것임에 유의하여야 한다. Hereinafter, preferred embodiments of the present invention will be described in more detail. It should be understood, however, that the invention can be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. It should be noted that the embodiments of the present invention described below are intended to sufficiently convey the spirit of the present invention to those skilled in the art.
본 발명은 인삼열매에 포함된 진세노사이드의 체내대사를 촉진하고, 체내에서의 흡수율을 증대시킨 인삼열매 추출물의 제조방법을 나타낸다. The present invention shows a method for producing a ginseng fruit extract that promotes the metabolism of ginsenosides contained in the ginseng fruit and increases the absorption rate in the body.
위와 같은 목적을 달성하기 위하여 본 발명자는 세척, 열수 증수 및 건조된 인삼열매를 100매쉬의 입도로 분쇄한 후, 용매에 용해시킨 후 알파-갈락토시다제, 펙티나제, 셀룰라제, 락타제 또는 헤스퍼리디나제 중 선택된 1종 또는 2종 이상과 효소 반응시켜 인삼열매에 함유된 진세노사이드가 체내에서 용이하게 분해되어 대사될 수 있도록 하였다. In order to achieve the above object, the present inventors grind the washed, hydrothermally evaporated and dried ginseng fruit to a particle size of 100 mesh, dissolve in a solvent, and then alpha-galactosidase, pectinase, cellulase, lactase Or enzyme reaction with one or two or more selected from hesperidinase so that ginsenosides contained in ginseng fruit can be easily degraded and metabolized in the body.
또한, 본 발명자는 효소 반응된 인삼열매 조성액에 다량의 미네랄과 식이섬유를 갖으며 항산화 효과가 우수한 EM 발효 함초액을 혼합한 후 인삼열매 추출물을 제조함으로써 섭취시 장내에서의 진세노사이드의 흡수율을 증대시켜 사포닌의 약리작용 효율을 증대하였다.In addition, the present inventors prepared a ginseng fruit extract by mixing EM fermented saline solution with a large amount of minerals and dietary fiber and excellent antioxidant effect in the enzyme-reacted ginseng fruit composition to increase the absorption rate of ginsenoside in the intestine upon ingestion. It increased the pharmacological efficiency of saponin.
실시예Example
1. 인삼열매의 증숙 및 건조1. Steaming and drying of ginseng fruit
본 발명에서 인삼열매에 함유되는 진세노사이드의 성분함량을 증대시키거나 다양한 진세노사이드가 생성되도록 하기 위해여 인삼으로부터 채취한 인삼열매를 정제수를 세척한 다음, 증숙하는 것이 바람직하다. In the present invention, in order to increase the content of ginsenosides contained in the ginseng fruit or to produce various ginsenosides, it is preferable to wash the purified ginseng fruit from purified ginseng and then steam.
본 발명에서 인삼열매의 증숙의 일예로 80∼100℃의 열수로 20∼30분씩 수회 실시하거나 80∼120℃의 수증기로 20∼30분씩 수회 실시할 수 있다. 증숙의 회수로는 1~10회 동안 할 수 있으나, 3회 정도가 적당하다. As an example of steaming ginseng fruit in the present invention, it may be performed several times for 20 to 30 minutes with hot water of 80 to 100 ° C or several times for 20 to 30 minutes with steam of 80 to 120 ° C. Steaming can be done for 1 to 10 times, but about 3 times is appropriate.
증숙한 인삼열매에서 물기 및/또는 수증기를 제거하기 위해 건조를 실시한다. 상기 인삼열매의 건조는 열수 및/또는 수증기로 수회 증숙하는 경우 1회의 증숙이 끝난 후 바로 건조를 실시한 후 다시 열수 및/또는 수증기로 증숙 및 건조를 실시하는 것이 좋다. 상기 인삼열매의 증숙 후 건조는 인삼열매의 수분함량이 12±15%가 되도록 하는 것이 좋다. Drying is carried out to remove water and / or water vapor from steamed ginseng fruit. When the ginseng fruit is dried several times with hot water and / or steam, drying is performed immediately after one steaming, and then steaming and drying with hot water and / or steam again. After steaming the ginseng fruit, the moisture content of the ginseng fruit may be 12 ± 15%.
상기 인삼열매의 증숙 후 건조의 일예로 상온∼40℃의 온도에서 인삼열매의 물기 및/또는 수증기를 제거하여 수분함량이 12~15% 정도로 실시할 있으며, 건조의 예로서는 상온에서의 자연건조, 열풍을 이용한 열풍건조, 저온에서의 냉동건조 중에서 선택된 어느 하나 이상을 이용할 수 있다.
As an example of the drying after steaming the ginseng fruit, moisture and / or water vapor of the ginseng fruit are removed at a temperature of room temperature to 40 ° C., and the water content is about 12 to 15%. Examples of drying are natural drying and hot air at room temperature. Any one or more selected from hot air drying and freeze drying at low temperature may be used.
2. 증숙 및 건조한 인삼열매를 분쇄하여 효소반응2. Enzymatic reaction by grinding steamed and dried ginseng fruit
인삼에는 다양한 종류의 진세노사이드가 함유되어 있는데, 이러한 진세노사이드는 바로 인체에 흡수되는 것이 아니라 체내효소와 같은 체내대사물질에 의해 인체의 장에서 흡수된다. 체내대사 물질의 예로서는 진세노사이드 Mc-1과 Mc를 그 예로 들 수 있다. Ginseng contains various types of ginsenosides. These ginsenosides are not directly absorbed by the human body but are absorbed by the intestine of the human body by metabolic substances such as enzymes in the body. Examples of metabolic substances include ginsenosides Mc-1 and Mc.
진세노사이드 Mc-1이나 Mc는 주로 홍삼에 미량 함유되어 있는 진세노사이드로서, 진통작용, 코티코스테론 분비 촉진작용, 신장 사구체 비대 억제 작용, 간세포의 지질과산화 억제 작용, 골수세포, DNA, RNA, 단백질 및 지질 합성촉진작용 등의 기능이 있는 디올계열의 진세노사이드 Rc를 섭취했을 때 생성되는 물질이다. Ginsenosides Mc-1 and Mc are ginsenosides mainly contained in red ginseng, analgesic, corticosterone secretion, renal glomerular hypertrophy, hepatic lipid peroxidation, bone marrow cells, DNA, RNA It is a substance produced when ingesting diol-based ginsenoside Rc having functions such as protein and lipid synthesis promoting action.
본 발명자는 인삼열매의 사포닌에는 진세노사이드 Rb1, Rb2, Rd, Rc 등 약 30여종의 다양한 진세노사이드를 함유하고 있고, 이중 진세노사이드 Rc는 약 12%정도임을 발견하였다. 상기 진세노사이드 Rc는 알파-갈락토시다제, 펙티나제, 셀룰라제, 락타제 또는 헤스퍼리디나제 등과 같은 효소와 효소반응 시 진세노사이드의 체내대사물질인 진세노사이드 Mc-1, Mc를 생성한다. The present inventors found that ginsenoside saponins contain about 30 kinds of ginsenosides such as ginsenosides Rb1, Rb2, Rd, and Rc, of which ginsenoside Rc is about 12%. The ginsenoside Rc is a ginsenoside Mc-1, Mc which is an internal metabolite of ginsenosides upon enzyme reaction with an enzyme such as alpha-galactosidase, pectinase, cellulase, lactase or hesperidinase, and the like. Create
본 발명자는 체내대사질의 생성을 위하여 증숙 및 건조된 인삼열매를 약 100매쉬(mesh) 정도를 분쇄한 후 수용성 용매 또는 수용성 용매와 유기 용매가 혼합된 용매에 용해시켜 알파-갈락토시다제, 펙티나제, 셀룰라제, 락타제 또는 헤스퍼리디나제 중 선택된 1종 또는 2종 이상과 효소 반응시켜 인삼열매에 함유된 진세노사이드 Rc로부터 진세노사이드 Mc-1 및 Mc의 생성을 촉진하는 것이 바람직하다는 것을 발견하였다. The present inventors grind about 100 mesh of steamed and dried ginseng fruit for generation of metabolism in the body, and then dissolve it in an aqueous solvent or a solvent mixed with an aqueous solvent and an organic solvent to produce alpha-galactosidase, peck It is preferable to promote the production of ginsenosides Mc-1 and Mc from ginsenoside Rc contained in ginseng fruit by enzymatic reaction with one or two or more selected from tinase, cellulase, lactase or hesperidinase. I found out.
상기 효소반응의 반응조건은, 반응온도 10~80℃, pH 2.0~8.0, 기질농도 0.001~10중량%, 효소농도 0.0001~10중량%, 반응시간 5~1500시간을 하는 것이 바람직하다. 반응온도가 10℃보다 낮거나 80℃를 초과하는 경우 효소반응이 원활하게 이루어지지 않아 진세노사이드 Mc-1 및 Mc의 생성량이 미미하기 때문이다. The reaction conditions of the enzyme reaction, the reaction temperature 10 ~ 80 ℃, pH 2.0 ~ 8.0, substrate concentration 0.001 ~ 10% by weight, enzyme concentration 0.0001 ~ 10% by weight, the reaction time is preferably 5 to 1500 hours. If the reaction temperature is lower than 10 ℃ or more than 80 ℃ because the enzyme reaction is not made smoothly because the amount of ginsenoside Mc-1 and Mc is insignificant.
상기 수용성 용매로는 물, 초산, 인산, 시트레이트 또는 시트레이트-인산완충용액을 사용하고 pH는 2~7 범위로 조절하며, 유기용매로는 에탄올과 같은 알콜용매, 아세토니트릴, 디옥산 또는 디메틸설폭사이드 등을 사용할 수 있다.
As the water-soluble solvent, water, acetic acid, phosphoric acid, citrate or citrate-phosphate buffer solution is used and the pH is adjusted in the range of 2-7, and as an organic solvent, an alcohol solvent such as ethanol, acetonitrile, dioxane or dimethyl Sulfoxide and the like can be used.
3. 미네랄 및 식이섬유가 풍부한 EM발효함초액과의 혼합3. Mix with EM fermented supernatant rich in mineral and dietary fiber
상기 2단계에서 진세노사이드의 체내대사를 촉진시키기 위하여 효소반응된 인삼열매의 조성물은 진세노사이드의 채내 흡수율을 보다 높기 위하여 EM발효함초액과 혼합된다. In the second step, the composition of the ginseng fruit which has been enzyme-activated to promote the metabolism of ginsenosides is mixed with the EM fermentation vinegar solution to increase the absorption rate of ginsenosides in the body.
본 발명에서 사용된 EM발효함초액은 EM(Effective Micro-organisms)활성액 : 함초분말 : 설탕 : 물의 혼합비율(%)을 각각 5 : 4 : 5 : 86의 비율로 혼합하여 밀폐한 후 35℃~40℃에서 3일 내지 7일간 발효시켜 만든 것을 사용할 수 있다. EM fermentation supernatant used in the present invention is EM (Effective Micro-organisms) active liquid: seaweed powder: sugar: water mixed ratio (%) of the mixture of 5: 4: 5: 5: 86 and then sealed to 35 ℃ ~ It can be used that made by fermentation for 3 to 7 days at 40 ℃.
EM활성액은 항산화물질을 생성하는 일련의 유용 미생물균으로서, 의료분야에서서 활발하게 이용되고 있고, 이들 미생물균들은 여러 환경에서 유익한 기능을 수행하며, 서로 공생하면서 상승효과를 일으켜 항산화(antioxidant) 능력을 증가시킨다. EM active liquids are a series of useful microorganisms that produce antioxidants, which are actively used in the medical field, and these microorganisms perform beneficial functions in various environments, synergistically synergize with each other, and have antioxidant ability. To increase.
또한 함초에는 이미 잘알려진 바와 같이, 칼슘(Ca), 마그네슘(Mg), 칼륨(K), 철(Fe), 인(P), 망간(Mn), 아연(Zn), 요오드(I) 등과 같은 다양한 미네랄을 함유하고 있고, 식이섬유의 함량이 40%이상 함유하고 있는 염생식물로서 그 약리작용을 이미 널리 잘 알려져 있다. In addition, the seaweeds, as is well known, such as calcium (Ca), magnesium (Mg), potassium (K), iron (Fe), phosphorus (P), manganese (Mn), zinc (Zn), iodine (I), etc. As a salty plant containing various minerals and containing more than 40% of dietary fiber, its pharmacological action is already well known.
이중 식이섬유는 사람의 소화효소에 의해서도 소화되지 않고 몸 밖으로 배출되는 고분자 탄수화물로서 장내에 장시간 동안 머물게 하여 대장 내의 세균에 좋은 영향을 끼쳐 발암 물질의 작용을 억제하고 대장의 운동을 촉진시켜 장내의 유용한 성분의 흡수율을 높일 수 있다.
The dietary fiber is a high-molecular carbohydrate that is not digested by human digestive enzymes and is excreted out of the body.It stays in the intestine for a long time and has a good effect on the bacteria in the intestine. The water absorption of a component can be raised.
4. 인삼열매 추출물의 제조4. Preparation of Ginseng Fruit Extract
상기 3단계를 거쳐 효소반응되어 EM발효함초액과 혼합된 인삼열매의 조성물은 열수추출 또는 유기용매추출에 의해 인삼열매 추출물을 얻을 수 있다. The composition of ginseng fruit, which is enzymatically reacted and mixed with EM fermentation supernatant through the above three steps, may obtain ginseng fruit extract by hot water extraction or organic solvent extraction.
상기에서 효소반응된 인삼열매 조성물의 중량 대비 3∼10배량의 정제수에 넣고 80∼120℃에서 최초 정제수의 함량이 10∼50%가 될 때까지 추출한 후 여과하여 40~50℃에서 감압 농축하여 인삼열매 추출을 얻었다. Into the purified water of 3-10 times the weight of the enzyme-reacted ginseng fruit composition in the above water extracted at 80 ~ 120 ℃ until the content of the purified water to 10 to 50%, filtered and concentrated under reduced pressure at 40 ~ 50 ℃ ginseng A fruit extract was obtained.
상기에서 효소반응된 인삼열매의 유기용매추출물의 일예로서는, 효소반응된 인삼열매 조성물의 중량대비 2∼5배량의 유기용매에 넣고 60∼75℃에서 5시간∼48시간 동안 추출한 후 여과한 다음 상기 유기용매를 제거하여 인삼열매의 추출물을 얻을 수 있다.As an example of the organic solvent extract of the enzyme-reacted ginseng fruit, it is put in an organic solvent of 2 to 5 times the weight of the enzyme-reacted ginseng fruit composition and extracted for 5 hours to 48 hours at 60-75 ℃ and then filtered The organic solvent can be removed to obtain an extract of ginseng fruit.
상기 유기용매로는 에탄올과 같은 알코올 용매를 사용하는 것이 바람직하다.
It is preferable to use an alcohol solvent such as ethanol as the organic solvent.
본 발명은 상기에서 언급한 방법에 의해 제조한 진세노사이드 함량이 풍부한 인삼열매추출물을 포함하는 건강보조식품을 포함하며, 상기 건강보조식품은 액상의 음료제형으로 제공될 수 있다. The present invention includes a health supplement comprising a ginseng fruit extract rich in ginsenoside content prepared by the above-mentioned method, the health supplement may be provided in a liquid beverage formulation.
상기의 건강보조식품의 일예로 인삼열매의 추출물을 분무건조와 같은 방법을 이용하여 분말화하고, 이러한 분말을 정제, 환, 산제, 타브렛, 캡슐제 중에서 선택된 어느 하나 이상의 고상 제형으로 제공될 수 있다. For example, the extract of ginseng fruit may be powdered using a method such as spray drying, and the powder may be provided in any one or more solid dosage forms selected from tablets, pills, powders, tablets, and capsules. have.
상술한 바와 같이 본 발명의 실시 예에 따른 인삼열매 추출물은 증숙, 건조되어 분말화된 인삼열매 분말을 효소와 효소반을 시켜 채내대사물질을 생성하고, 채내대사물질이 풍부하게 함유된 효소반응 인삼열매 조성물을 미네랄과 식이섬유가 풍부한 EM발효함초액과 혼합하여 추출함으로써 장내에서 진세노사이즈의 흡수를 효과적으로 할 수 있어 진세노사이드의 약리작용을 극대할 수 있다.
As described above, the ginseng fruit extract according to an embodiment of the present invention is steamed and dried to produce a metabolism of the powdered ginseng fruit powder by enzyme and enzyme half, and the enzyme-reactive ginseng containing abundant metabolism material By extracting the fruit composition mixed with mineral and dietary fiber-rich EM fermentation vinegar solution can be effectively absorbed ginsenosize in the intestine can maximize the pharmacological action of ginsenosides.
Claims (6)
The method according to claim 1, wherein the enzyme reaction conditions are ginseng, characterized in that the reaction temperature 10 ~ 80 ℃, pH 2.0 ~ 8.0, substrate concentration 0.001 ~ 10% by weight, enzyme concentration 0.0001 ~ 10% by weight, reaction time 5 ~ 48 hours Method of preparing fruit extracts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100131333A KR101051519B1 (en) | 2010-12-21 | 2010-12-21 | Method for manufacturing ginseng-berry extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100131333A KR101051519B1 (en) | 2010-12-21 | 2010-12-21 | Method for manufacturing ginseng-berry extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101051519B1 true KR101051519B1 (en) | 2011-07-22 |
Family
ID=44924023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100131333A KR101051519B1 (en) | 2010-12-21 | 2010-12-21 | Method for manufacturing ginseng-berry extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101051519B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017018791A1 (en) * | 2015-07-27 | 2017-02-02 | 주식회사 네추럴에프앤피 | Ginseng fruit extract containing alcoholic liver damage preventive functional ingredient, and preparation method therefor |
KR20180077968A (en) * | 2016-12-29 | 2018-07-09 | 한국과학기술연구원 | Culturing method of ginseng berries |
KR102349207B1 (en) * | 2021-11-10 | 2022-01-10 | 최용석 | A method for extracting the active ingredient of the raw material hub at a high content and a composition containing the high content active ingredient extracted therefrom |
CN114053317A (en) * | 2020-07-29 | 2022-02-18 | 株式会社爱茉莉太平洋 | Composition for wound healing |
KR20220142004A (en) | 2021-04-14 | 2022-10-21 | 좋은영농조합법인 | A food composition for the improvement or prevention of asthma comprising extract of ginseng berry |
KR20220152837A (en) * | 2021-05-10 | 2022-11-17 | 농업회사법인 자연그대로 주식회사 | Ginseng-berry extract and its manufacturing method |
KR20220161987A (en) | 2021-05-31 | 2022-12-07 | 진안당 영농조합법인 | Halophyte complex extrait containing a red ginseng, and the method for manufacturing of complex extrait |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000032595A (en) * | 1998-11-16 | 2000-06-15 | 김원규 | Automatic receiving terminal device and control method therefor |
JP2003040791A (en) | 2002-07-05 | 2003-02-13 | Itbs:Kk | Dried powder of extract from fruit of panax ginseng |
KR100852138B1 (en) | 2007-11-14 | 2008-08-13 | 성인환 | Manufacturing method for extract of fruit and ginseng spray |
KR20090010673A (en) * | 2007-07-24 | 2009-01-30 | 성인환 | Fermented ginseng fruit and manufacturing method of fermented ginseng fruit extract |
-
2010
- 2010-12-21 KR KR1020100131333A patent/KR101051519B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000032595A (en) * | 1998-11-16 | 2000-06-15 | 김원규 | Automatic receiving terminal device and control method therefor |
JP2003040791A (en) | 2002-07-05 | 2003-02-13 | Itbs:Kk | Dried powder of extract from fruit of panax ginseng |
KR20090010673A (en) * | 2007-07-24 | 2009-01-30 | 성인환 | Fermented ginseng fruit and manufacturing method of fermented ginseng fruit extract |
KR100852138B1 (en) | 2007-11-14 | 2008-08-13 | 성인환 | Manufacturing method for extract of fruit and ginseng spray |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017018791A1 (en) * | 2015-07-27 | 2017-02-02 | 주식회사 네추럴에프앤피 | Ginseng fruit extract containing alcoholic liver damage preventive functional ingredient, and preparation method therefor |
KR20170013170A (en) * | 2015-07-27 | 2017-02-06 | 대한민국(농촌진흥청장) | The Ginseng-Berry extract including alcoholic liver injury prevention functional ingredients and method for manufacturing it |
KR102005031B1 (en) * | 2015-07-27 | 2019-07-31 | 대한민국(농촌진흥청장) | The Ginseng-Berry extract including alcoholic liver injury prevention functional ingredients and method for manufacturing it |
KR20180077968A (en) * | 2016-12-29 | 2018-07-09 | 한국과학기술연구원 | Culturing method of ginseng berries |
KR102044839B1 (en) * | 2016-12-29 | 2019-12-02 | 한국과학기술연구원 | Culturing method of ginseng berries |
CN114053317A (en) * | 2020-07-29 | 2022-02-18 | 株式会社爱茉莉太平洋 | Composition for wound healing |
KR20220142004A (en) | 2021-04-14 | 2022-10-21 | 좋은영농조합법인 | A food composition for the improvement or prevention of asthma comprising extract of ginseng berry |
KR20220152837A (en) * | 2021-05-10 | 2022-11-17 | 농업회사법인 자연그대로 주식회사 | Ginseng-berry extract and its manufacturing method |
KR102634654B1 (en) * | 2021-05-10 | 2024-02-08 | 자연그대로(주) | Manufacturing method of ginseng-berry extract |
KR20220161987A (en) | 2021-05-31 | 2022-12-07 | 진안당 영농조합법인 | Halophyte complex extrait containing a red ginseng, and the method for manufacturing of complex extrait |
KR102349207B1 (en) * | 2021-11-10 | 2022-01-10 | 최용석 | A method for extracting the active ingredient of the raw material hub at a high content and a composition containing the high content active ingredient extracted therefrom |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102763742B (en) | Maca instant tea and production method thereof | |
KR101051519B1 (en) | Method for manufacturing ginseng-berry extract | |
KR100941160B1 (en) | Preparation of fermented rice punch | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
CN106177339A (en) | A kind of method preparing treatment gout herbal formulation | |
CN102349608B (en) | Healthcare product combination for clearing and nourishing throat and preparation method thereof | |
CN103652692B (en) | Radish leaf nutritional chewable tablet and preparation method | |
CN106418111A (en) | Antioxidant extract derived from garlic stalks and preparation method thereof | |
CN108552369A (en) | A kind of tea-drinking preparation method for material of the active material containing golden camellia tea | |
KR20190112498A (en) | Whole Ginseng Composition Using Ginseng Roots, Leaves and Berries and Method of Preparing the Same | |
CN103584098A (en) | Maca almond tablet and preparation method thereof | |
CN105996036A (en) | Artichoke ferment tablets and preparation method thereof | |
Wolska et al. | Influence of temperature and brewing time of nettle (Urtica dioica L.) infusions on vitamin C content | |
CN103719855A (en) | Nutritious food and production method thereof | |
KR100959620B1 (en) | Making method of the dust tea by the low temperature extraction | |
CN102972838A (en) | Chestnut flower health drink and preparation method thereof | |
CN105851764A (en) | Cyclocarya paliurus leaf solid beverage, as well as preparation method and application thereof | |
CN109846932A (en) | A kind of extraction purification and technology of preparing of mulberries slag blood-sugar decreasing active | |
CN104366356A (en) | Method for preparing functional nourishment by using deep-processed sweet potatoes | |
CN102228201B (en) | Chickpea polysaccharide nutrition powder and preparation method thereof | |
CN108157552A (en) | A kind of preparation method of golden camellia tea active material lozenge | |
CN108157545A (en) | A kind of guava leaf liquid beverage and preparation method thereof | |
CN102719337A (en) | Fungus health beer | |
CN105053407A (en) | Preparation method of pitaya peel sweet tea | |
KR20200132439A (en) | Method for Manufacturing Fermented Ginseng Tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140702 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160718 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180705 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190710 Year of fee payment: 9 |
|
R401 | Registration of restoration |